跳转至内容
Merck
CN

HLA class II alleles and multiple sclerosis in Tunisian patients.

Clinical neurology and neurosurgery (2010-08-10)
Amira Messadi, Fekih-Mrissa Najiba, Slah Ouerhani, Jemel Zaweli, Ines Louatti, Sami Layouni, Brahim Nciri, Ghaya Bouaicha, Wafa Kouki, Mondher Yedeas, Aly Raies, Ridha Mrissa, Nasreddine Gritli
摘要

The aim of our study was to investigate the association of HLA-DRB1 and -DQB1 alleles with multiple sclerosis (MS) in a Tunisian population and their effect on age at onset and disease severity. 58 MS patients and 105 healthy controls were genotyped for HLA class II alleles by PCR-SSP technique. An association of MS with HLA-DRB1*15 was found (14.7% vs 3.8%, OR (95% CI)=4.34 (1.69-11.39), p(c)=2.5×10(-3)) after Bonferroni's correction. Moreover, the DRB1*15-DQB1*06 (13.8% vs 2.8%, OR (95% CI)=5.44 (1.92-17.41), p(c)=1.1×10(-3)) and DRB1*04-DQB1*04 (8.6% vs 1.9%, OR (95% CI)=4.86 (1.36-21.62), p(c)=0.028) haplotypes were found to confer a susceptibility to multiple sclerosis. To our knowledge, this is the first study performed to analyze the association of HLA-DRB1/DQB1 alleles on MS susceptibility in Tunisia. The modern Tunisian gene pool shows some degree of heterogeneity and reflects a significant gene flow from Mediterranean regions.